Log in | Join Free | china | japan | germany

INDEX NAME NOT YET ASSIGNED

Request For Quotation
INDEX NAME NOT YET ASSIGNED Suppliers list
Company Name: Cayman Chemical Company  
Tel: (800) 364-9897
Email: cayman@caymanchem.com
Products Intro: Product Name:AM2201 N-(4-hydroxypentyl) metabolite-d5
CAS:2747914-09-4
INDEX NAME NOT YET ASSIGNED Basic information
Product Name:INDEX NAME NOT YET ASSIGNED
Synonyms:(1-(5-fluoro-4-hydroxypentyl)-1H-indol-3-yl-2,4,5,6,7-d5)(naphthalen-1-yl)methanone
CAS:2747914-09-4
MF:C24H22FNO2
MW:375.44
EINECS:
Product Categories:
Mol File:2747914-09-4.mol
INDEX NAME NOT YET ASSIGNED Structure
INDEX NAME NOT YET ASSIGNED Chemical Properties
solubility Dichloromethane: 20 mg/ml; DMF: 20 mg/ml; DMSO: 20 mg/ml; Ethanol: 5 mg/ml
Safety Information
MSDS Information
INDEX NAME NOT YET ASSIGNED Usage And Synthesis
DescriptionAM2201 N-(4-hydroxypentyl) metabolite-d5 contains five deuterium atoms at the 2, 4, 5, 6, and 7 positions. It is intended for use as an internal standard for the quantification of AM2201 N-(4-hydroxypentyl) metabolite by GC- or LC-mass spectrometry. AM2201 is a potent synthetic cannabinoid (CB) with Ki values of 1.0 and 2.6 nM for the CB1 and CB2 receptors, respectively.1 AM2201 N-(4-hydroxypentyl) metabolite is an expected urinary metabolite of AM2201, based on the known metabolism of similar compounds.2 Its biological actions are unknown.
References1. Makriyannis, A., and Deng, H. Cannabimimetic indole derivatives US7241799B2,(2001).
2. Wintermeyer, A., M?ller, I., Thevis, M., et al. In vitro phase I metabolism of the synthetic cannabimimetic JWH-018 Anal. Bioanal. Chem. 398(5),2141-2153(2010).
INDEX NAME NOT YET ASSIGNED Preparation Products And Raw materials
Tag:INDEX NAME NOT YET ASSIGNED(2747914-09-4) Related Product Information